论文部分内容阅读
上海第一医学院中山医院肝癌研究室主任汤钊猷教授1954年毕业于上海第一医学院,1968年开始从事肝癌防治和研究,是知名的中年肝癌专家。近几年,中山医院肝癌室取得了一系列突出成就:在诊断上,用甲胎蛋白诊断早期肝癌的准确率达90％以上,并能准确定位;在治疗上,五年生存率由1961～1970年的2.6％上升为1977～1982年的20.6％,亚临床肝癌(无症状的早期肝癌)手术切除后的五年生存率高达72.9％;在理论上,系统地提出了有关亚临床肝癌的新概念,(包括:肝癌自然病程约二年左右、肝癌多数系单中心发生、甲胎蛋白是诊断早期肝癌的可靠指标以及早期肝癌外科手术非规则切除等。)受到国内外肝癌学界的高度评价。最近,本刊记者就开展国际学术交流、促进科技发展问题访问了汤钊猷教授。
Shanghai First Medical College Zhongshan Hospital Liver Cancer Research Director Professor Tang Zhao 毕 1954 graduated from the Shanghai First Medical College, 1968 began to engage in prevention and treatment of liver cancer, is well-known middle-aged liver cancer experts. In recent years, Zhongshan Hospital, made a series of outstanding achievements in liver cancer room: in the diagnosis, the accuracy of diagnosis of early liver cancer with AFP is more than 90%, and can accurately locate; in the treatment, the five-year survival rate from 1961 ~ 2.6% in 1970 rose to 20.6% in 1977 ~ 1982, and the five-year survival rate of sub-clinical liver cancer (asymptomatic early stage liver cancer) after resection was as high as 72.9%. In theory, (Including: natural course of liver cancer about two years or so, the majority of single-center liver cancer occurred, a-fetoprotein is a reliable indicator of early diagnosis of liver cancer and early liver cancer surgical resection, etc.) highly praised by domestic and international liver cancer scholars . Recently, our correspondents visited Professor Tang Zhaojian on the issue of international academic exchanges and the promotion of science and technology development.